FDA Approves Colorado Canadian Drug Import Plan
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- The FDA approved Colorado's plan to import certain prescription drugs from Canada, making it the second U.S. state granted such authorization
- Florida became the first state to earn FDA approval for drug importation in 2024 but has yet to import any drugs from Canada, partly due to pushback from the Canadian drug industry and fears the program would affect Canada's drug supply
- The first Trump administration officially endorsed the practice in 2020 by publishing a regulation allowing states and Indian tribes to propose import plans
- The Biden administration affirmed the importation rule with an executive order in 2021, giving the policy bipartisan and cross-administration support
- The FDA extended Florida's approval by six months in May to give the state more time to get its program up and running
- State importation programs have proved extremely difficult to carry out despite bipartisan support, raising questions about whether Colorado will face similar operational hurdles
Why it matters: The gap between regulatory approval and actual drug imports is the key story: Florida received the same green light in 2024 and still hasn't shipped a single Canadian drug, with the FDA granting a six-month extension in May. For Colorado patients hoping for cheaper prescriptions, this track record suggests approval is a necessary but insufficient step, and the Canadian drug industry's pushback remains a concrete obstacle.
